Significance of neoadjuvant therapy for borderline resectable pancreatic cancer: a multicenter retrospective study.
Hiroshi KuraharaHiroyuki ShinchiTakao OhtsukaYoshihiro MiyasakaTaketo MatsunagaHirokazu NoshiroTomohiko AdachiSusumu EguchiNaoya ImamuraAtsushi NanashimaKazuhiko SakamotoHiroaki NaganoMasayuki OhtaMasafumi InomataAkira ChikamotoHideo BabaYusuke WatanabeKazuyoshi NishiharaMasafumi YasunagaKoji OkudaShoji NatsugoeMasafumi NakamuraPublished in: Langenbeck's archives of surgery (2019)
Resection after NAT in patients with BRPC is associated with longer OS and lower rates of both invasion to the surrounding tissues and lymph node metastasis.